Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries

Coronavirus disease 2019 (COVID-19) is an evolving global public health crisis in need of therapeutic options. Passive immunization of monoclonal antibodies (mAbs) represents a promising therapeutic strategy capable of conferring immediate protection from SARS-CoV-2 infection. Herein, we describe th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Tom Z., Garg, Pankaj, Wang, Linya, Willis, Jordan R., Kwan, Eric, Hernandez, Ana G Lujan, Tuscano, Emily, Sever, Emily N., Keane, Erica, Soto, Cinque, Mucker, Eric M., Fouch, Mallorie E., Davidson, Edgar, Doranz, Benjamin J., Kailasan, Shweta, Aman, M. Javad, Li, Haoyang, Hooper, Jay W., Saphire, Erica Ollmann, Crowe, James E., Liu, Qiang, Axelrod, Fumiko, Sato, Aaron K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726723/
https://www.ncbi.nlm.nih.gov/pubmed/34967699
http://dx.doi.org/10.1080/19420862.2021.2002236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726723/
https://www.ncbi.nlm.nih.gov/pubmed/34967699
http://dx.doi.org/10.1080/19420862.2021.2002236

Ejemplares similares